Algernon

Brain Scan Tech

Dr. Benjamin Allen, Ph.D.

Our Mission

To eradicate misdiagnosis of individuals with FTD

Using machine learning in bioimaging to streamline the patient diagnosis journey

2014

2018

what is

FTD?

frontotemporal degeneration

A neurodegenerative brain disease caused by atrophy in the frontal and temporal lobes of the brain

What the Stats Say

Average diagnosis for FTD takes

>4 YEARS

As many as 90% of FTD patients receive an initial misdiagnosis

Criminal behavior present in 37% of bvFTD cases

Our Solution

Algernon technology

  • Detects atrophy easily missed by naked eye
  • Compares to norms
  • Avoids human error component of the diagnosis process


Our Story

Founded by Dr. Benjamin Allen, Ph.D., The Algernon Project is currently working to raise awareness for this technology and to see its algorithm adopted on medical imaging devices across the globe.


After nearly a decade of misdiagnosis for his father-in-law, Dr. Allen developed the Algernon algorithm to assist medical personnel by alerting them to atrophy easily missed by the naked eye.

Follow The Algernon Project

Company Location

United States of America

Email Address

contact.algernon@gmail.com

Connect with Dr. Allen